Valuation : G MEDPAR

Market Cap 723K 622K 586K 534K 999K 68.8M 1M 6.94M 2.68M 35.05M 2.71M 2.66M 111M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.17M 2.04M 1.86M 3.48M 240M 3.49M 24.2M 9.35M 122M 9.46M 9.26M 387M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
Current month+9,900.00%
Current year-50.00%
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.09
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
31/3/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
31/3/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.35M 4.1M 3.73M 6.99M 481M 7.01M 48.57M 18.77M 245M 18.99M 18.58M 777M 4.42M 3.8M 3.58M 3.26M 6.11M 421M 6.13M 42.44M 16.4M 214M 16.6M 16.24M 679M
Net income -14.76M -12.7M -11.96M -10.9M -20.39M -1.4B -20.47M -142M -54.77M -715M -55.42M -54.21M -2.27B -13.52M -11.63M -10.96M -9.98M -18.68M -1.29B -18.75M -130M -50.18M -655M -50.77M -49.67M -2.08B
Net Debt 2.41M 2.07M 1.95M 1.78M 3.33M 229M 3.34M 23.12M 8.94M 117M 9.04M 8.85M 370M 1.8M 1.55M 1.46M 1.33M 2.48M 171M 2.49M 17.26M 6.67M 87.11M 6.75M 6.6M 276M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GMVDF Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!